QR Kodea

Cost Savings of Expedited Care with Upfront Next-Generation Sequencing Testing versus Single-Gene Testing among Patients with Metastatic Non-Small Cell Lung Cancer Based on Current Canadian Practices

This study assessed the total costs of testing, including the estimated costs of delaying care, associated with next-generation sequencing (NGS) versus single-gene testing strategies among patients with newly diagnosed metastatic non-small cell lung cancer (mNSCLC) from a Canadian public payer persp...

Deskribapen osoa

Gorde:
Egile Nagusiak: Brandon S. Sheffield, Kiefer Eaton, Bruno Emond, Marie-Hélène Lafeuille, Annalise Hilts, Patrick Lefebvre, Laura Morrison, Andrea L. Stevens, Emmanuel M. Ewara, Parneet Cheema
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: MDPI AG 2023-02-01
Saila:Current Oncology
Gaiak:
non-small cell lung cancer
economic model
next-generation sequencing
testing costs
medical costs
Sarrera elektronikoa:https://www.mdpi.com/1718-7729/30/2/180
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak